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Abstract
Purpose : To determine the cross-sectional association between aspirin use and DR
among persons with diabetes in a population-based study.
 
 
Methods : Participants aged >40 years were recruited from the Singapore Epidemiology
of Eye Diseases (SEED) Study. Diabetes was de ned based on random glucose >= 11.1
mmol/L, use of diabetic medication, or a previous physician diagnosis. Retinal
photographs were graded for DR according to the modi ed Airlie House classi cation.
Vision threatening diabetic retinopathy (VTDR) was further de ned as the presence of
severe non-proliferative DR, proliferative DR, or clinically signi cant macular oedema.
The association between aspirin use and the presence of any DR or VTDR was
determined using multivariable logistic regressions, adjusted for age, gender, ethnicity,
history of cardiovascular disease and other potential confounders.
Results : We included 2,075 participants with diabetes who had complete data about
systemic conditions and DR. Of these, 400(19.3%) had history of cardiovascular
diseases, 716 (34.5%) had any DR and 178 (8.6%) had VTDR. After adjusting for age,
gender, ethnicity, socio-economic status, body mass index, HbA1c, hypertension,
cholesterol levels, aspirin use was signi cantly associated with the likelihood of having
any DR (OR = 1.41, 95% CI: 1.09 to 1.81, P = 0.008) and VTDR (odds ratio [OR] =1.90, 95%
con dence interval [CI]: 1.29 to 2.82, P = 0.001). After further adjustment for the
presence of cardio-vascular diseases, the associations between aspirin and VTDR (OR =
1.66, 95% CI: 1.07 to 2.54, P = 0.021) remained signi cant. In analyses strati ed by
cardiovascular disease, the relationship between aspirin and VTDR was similar among
persons with (OR 1.67, 95% CI: 0.85 to 3.35, P = 0.139) and without (OR 1.48, 95% CI: 0.8
to 2.57, P = 0.187) cardiovascular disease.
Conclusions : Persons with diabetes who were on aspirin were more likely to have DR,
particularly VTDR. Whether these  ndings suggested a possible complication of taking
aspirin or whether it re ects increased severity of diabetes among patients on aspirin
requires further clinical studies.
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